O Shaughnessy Asset Management LLC Purchases Shares of 18,429 Pediatrix Medical Group, Inc. (NYSE:MD)

O Shaughnessy Asset Management LLC acquired a new position in Pediatrix Medical Group, Inc. (NYSE:MDFree Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 18,429 shares of the company’s stock, valued at approximately $242,000.

Other large investors have also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. raised its position in shares of Pediatrix Medical Group by 95.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after buying an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust raised its holdings in Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after purchasing an additional 1,040 shares in the last quarter. AlphaQuest LLC lifted its position in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC boosted its stake in Pediatrix Medical Group by 750.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after purchasing an additional 6,090 shares in the last quarter. Finally, FMR LLC increased its position in shares of Pediatrix Medical Group by 220.6% during the 3rd quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after purchasing an additional 6,771 shares during the period. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Pediatrix Medical Group stock opened at $13.35 on Friday. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The firm’s 50 day simple moving average is $14.33 and its 200-day simple moving average is $13.91. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The company has a market cap of $1.15 billion, a P/E ratio of -11.13, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32.

Pediatrix Medical Group (NYSE:MDGet Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. As a group, equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Upgrades and Downgrades

MD has been the subject of several research analyst reports. Truist Financial cut their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a report on Friday. UBS Group upped their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Macquarie began coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective on the stock. Finally, StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and an average price target of $16.75.

Get Our Latest Stock Report on MD

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Further Reading

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MDFree Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.